FMRP Mediates mGluR5-Dependent Translation of Amyloid Precursor Protein

Cited by (289)

Items 201–289 of 289

1. The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease
   Izabella B.Q. de Lima, Fabíola M. Ribeiro · 2021 · Current Neuropharmacology
2. Alterations in the Sp1 binding and Fmr-1 gene expression in the cortex of the brain during maturation and aging of mouse
   Pankaj Gaur, S. Prasad · 2014 · Molecular Biology Reports
3. Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
   Pamela R. Westmark, Beatrice Garrone, Rosella Ombrato, Claudio Milanese, Francesco Paolo Di Giorgio, Cara J. Westmark · 2021 · Frontiers in Molecular Neuroscience
4. On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model
   Mengyao Ma, Qinying Yu, Daniel G. Delafield, Yusi Cui, Zihui Li, Miyang Li, Wenxin Wu, Xudong Shi, Pamela R. Westmark, Alejandra Gutierrez et al. · 2023 · ACS Chemical Neuroscience
5. Genetic Reduction of the Translational Repressors FMRP and 4E ‐ BP2 Preserves Memory in Mouse Models of Alzheimer's Disease
   Felipe Campos Ribeiro, Danielle Cozachenco, Michael Parkhill, Brandon Rodrigue, Caio Borges, Jean‐Claude Lacaille, Karim Nader, Fernanda G. De Felice, Mychael V. Lourenco, Argel Aguilar‐Valles et al. · 2025 · Aging Cell
6. Trends and challenges in behavioural phenotype research
   Chris Oliver, Randi Jenssen Hagerman · 2007 · Journal of Intellectual Disability Research
7. Developing BACE-1 inhibitors for FXS
   Cara J. Westmark, Elizabeth Berry‐Kravis, Chrysanthy Ikonomidou, Jerry C. P. Yin, Luigi Puglielli · 2013 · Frontiers in Cellular Neuroscience
8. RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration
   Rita Nóbrega‐Martins, Beatriz Barros‐Santos, Georgia Papadimitriou, Ioannis Sotiropoulos, Benjamin L. Wolozin, Joana Margarida Silva · 2025 · Journal of Neurochemistry
9. Targeting RNA G-Quadruplexes for Potential Therapeutic Applications
   Satyaprakash Pandey, Prachi Agarwala, Souvik Maiti · 2017 · Topics in medicinal chemistry
10. Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome
    Richard D. McLane, Lauren Schmitt, Ernest V. Pedapati, Rebecca C. Shaffer, Kelli C. Dominick, Paul S. Horn, Christina Groß, Craig A. Erickson · 2019 · Frontiers in Integrative Neuroscience
11. The role of selected postsynaptic scaffolding proteins at glutamatergic synapses in autism-related animal models
    Veronika Melišková, Tomáš Havránek, Zuzana Bačová, Ján Bakoš · 2021 · Journal of Integrative Neuroscience
12. Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca2+ signaling in two rodent models of Alzheimer’s disease
    Aidan Kaar, Megan P. Weir, Mark George Rae · 2024 · Neuroscience Letters
13. Altered subcellular localization of fragile X mental retardation signaling partners and targets in superior frontal cortex of individuals with schizophrenia
    S. Hossein Fatemi, Timothy D. Folsom, PAUL D. THURAS · 2017 · Neuroreport
14. Use of biomarkers in the diagnosis of Alzheimer’s disease in adults with intellectual disability
    Aoife McFeely, Antoinette O’Connor, Seán Kennelly · 2024 · The Lancet Healthy Longevity
15. Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals
    Giulia Cencelli, Laura Pacini, Anastasia De Luca, Ilenia Messia, Antonietta Gentile, Yunhee Kang, Veronica Nobile, Elisabetta Tabolacci, Peng Jin, Maria Giulia Farace et al. · 2023 · Cells
16. Multi-layered transcriptomic analysis reveals a pivotal role of FMR1 and other developmental genes in Alzheimer's disease-associated brain ceRNA network
    Rafael Mina Piergiorge, Ronaldo da Silva Francisco, Ana Tereza Ribeiro de Vasconcelos, Cíntia Barros Santos-Rebouças · 2023 · Computers in Biology and Medicine
17. c‐Jun N‐terminal kinase regulates mG luR‐dependent expression of post‐synaptic FMRP target proteins
    Travis L. Schmit, James A. Dowell, Margaret E. Maes, Michael Wilhelm · 2013 · Journal of Neurochemistry
18. Effects of blocking mGluR5 on primate dorsolateral prefrontal cortical neuronal firing and working memory performance
    Sheng-Tao Yang, Min Wang, Veronica C. Galvin, Yang Yang, Amy F.T. Arnsten · 2020 · Psychopharmacology
19. SÍNDROME X FRÁGIL: DETECCIÓN E INTERVENCIÓN EN EL FENOTIPO CONDUCTUAL
    María Begoña Medina Gómez, Isabel García Alonso · 2016 · International Journal of Developmental and Educational Psychology Revista INFAD de psicología
20. Commentary: Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis
    Cara J. Westmark · 2017 · Frontiers in Molecular Neuroscience
21. Age- and Sex-dependent Differential Interaction of Nuclear trans-acting Factors with Fmr-1 Promoter in Mice Brain
    S. Prasad, Kanchan Singh · 2007 · Neurochemical Research
22. Toward an understanding of the role of the exposome on fragile X phenotypes
    Cara J. Westmark · 2023 · International review of neurobiology
23. DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related protein networks
    Ayse Uneri, Colin J. McArdle, Zhiyong Deng, Samuel H. Barth, Dirk Keene, Suzanne Craft, Kimberly F. Raab‐Graham · 2024 · Journal of Alzheimer s Disease
24. Evaluating the role of hnRNP‐C and FMRP in the cAMP‐induced APP metabolism
    Daniela Rivera, Ernesto Fedele, Umberto Maria Marinari, Maria Adelaide Pronzato, Roberta Ricciarelli · 2015 · BioFactors
25. APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder
    Deborah K. Sokol, Debomoy K. Lahiri · 2023 · Frontiers in Molecular Neuroscience
26. Supplementary Material and Methods
    Pamela C. Rosato, Eleni Anastasiadou, Nriti Garg, Dido Lenze, Francesco Boccellato, S. Vincenti, M. Severa, Eliana Marina Coccia, Riccardo Bigi, M. Cirone et al. · 2012
27. Dysregulated CRMP Mediates Circadian Deficits in a Drosophila Model of Fragile X Syndrome
    Juan Zhao, Jin Xue, Tengfei Zhu, Hua He, Huaixing Kang, Xuan Jade Jiang, Wen Huang, Ranhui Duan · 2021 · Neuroscience Bulletin
28. Structure and Functions of RNA G-quadruplexes
    Prakash Kharel, Pavel V. Ivanov · 2023 · RNA technologies
29. El síndrome X frágil: identificación del fenotipo y propuestas educativas
    María Begoña Medina Gómez · 2014 · Revista Española de Discapacidad
30. Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned
    Christina M. Harkins, Kelli C. Dominick, Logan K. Wink, Ernest V. Pedapati, Rebecca C. Shaffer, Sarah E. Fitzpatrick, Matthew H. Davenport, John A. Sweeney, Craig A. Erickson · 2017 · Pharmaceutical Medicine
31. Intellectual Disability in the Elderly
    Joanna C. Lim, Laurel J. Bessey, Pallavi Joshi, Lisa L. Boyle · 2018 · Springer eBooks
32. Site-Specific Fluorophore Labeling of Guanosines in RNA G-Quadruplexes
    Timo Hagen, Anna L. Malinowska, Helen Louise Lightfoot, Martina Bigatti, Jonathan Hall · 2019 · ACS Omega
33. Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient
    Pamela R. Westmark, Cara J. Westmark, Athavi Jeevananthan, James S. Malter · 2011 · Journal of Visualized Experiments
34. The Pathogenesis and Complications Associated with Autism Spectrum Disorder and Alzheimer’s Disease: A Comparative Study
    Ishfaq Ahmad Ahanger, Anurag Sharma, Asimul Islam · 2021 · Springer eBooks
35. Enfermedad de Alzheimer y síndrome X frágil: la vía Wnt-ß-catenina como mecanismo biológico común
    Mónica Alejandra Rosales Reynoso, Alejandra Berenice Ochoa-Hernández, Clara Ibet Juárez-Vázquez, Patricio Barros‐Núñez · 2012 · Revista de Neurología
36. The potential of G-quadruplexes as a therapeutic target for neurological diseases
    Norifumi Shioda, Yasushi Yabuki, Sefan Asamitsu · 2019 · Folia Pharmacologica Japonica
37. Translational symphony in (hnRNP) C major for APP
    Jerome E. Lee, Jeffrey Wilusz · 2010 · Nature Structural & Molecular Biology
38. The Genetics of Autism
    Deborah K. Sokol, Debomoy K. Lahiri · 2011 · Springer eBooks
39. Immunotherapy: An Approach to Treat Alzheimer’s Disease and Autism Spectrum Disorder
    Farah Maarfi, Ziaul Hasan, Afreen Khanam, Arbab Husain, Mohammad Haroon Khan, Mohd Yasir Khan · 2021 · Springer eBooks
40. Serum matrix metalloproteinase-9 (MMP9) and amyloid-beta protein precursor (APP) as potential biomarkers in children with Fragile-X syndrome: A cross sectional study
    Mohamed Bekheet, Lamiaa Ali Mansour, Rasha H. Elkaffas, Mona Ahmed Kamel, Mohamed A. Elmonem · 2023 · Clinical Biochemistry
41. Preparation of Synaptoneurosomes for the Study of Glutamate Receptor Function
    Cara J. Westmark, Pamela R. Westmark · 2019 · Methods in molecular biology
42. Fragile X Syndrome and Premutation‐Associated Disorders
    Randi Jenssen Hagerman · 2010 · Wiley eBooks
43. Reelin signaling as a translational rheostat: linking synaptic homeostasis to neurodevelopment and neurodegeneration
    Murat S. Durakoglugil · 2025 · Frontiers in Molecular Neuroscience
44. Semantic and syntactic language differences associated with the FMR1 premutation genotype
    Laura Friedman, William Matchin, Elizabeth Berry‐Kravis, Jessica Klusek · 2025 · Journal of Neurolinguistics
45. RNA G-quadruplexes in oncogene regulation and as emerging targets for cancer therapy
    Ziyan Liu, Xiao-yan Wang, Dandan Gong, Xuan Tang, Changfeng Man, Shiqi Zhang, Yu Fan · 2026 · Cell Communication and Signaling
46. Low concentrations of amyloid-beta oligomers induce synaptogenesis characteristic for mild cognitive impairment and alter the de novo proteome
    Kaiyu Wu, Suji Lee, Raquel Martínez-Serra, Lanyue Zhang, Steven Lynham, Karl-Peter Giese · 2026 · Translational Psychiatry
47. FRAGILE X SYNDROME AND ASSOCIATED DISORDERS IN ADULTHOOD
    Randi Jenssen Hagerman · 2009 · CONTINUUM Lifelong Learning in Neurology
48. Sleep-dependent cellular chemical changes in the aging brain
    Gordon X. Wang, Philippe Mourrain · 2020 · Elsevier eBooks
49. Frankincense Upregulates the FMR1 Gene and Alleviates AlCl3-Induced Memory Impairment in Rats
    Mohammad Khalaj‐Kondori, Mina Khajehdehi, Zeynab Shaghaghi Torkdari · 2021 · DOAJ (DOAJ: Directory of Open Access Journals)
50. Low normal FMR1 genotype in older adult women: Psychological well-being and motor function
    Jessica Klusek, Roger Newman‐Norlund, Amanda Jane Fairchild, Sarah E. Newman-Norlund, Sara Sayers, Jill Campbell Stewart, Elizabeth Berry‐Kravis, Julius Fridriksson · 2022 · Archives of Gerontology and Geriatrics
51. Role of mGluR5 and FMRP in mouse primary somatosensory cortex
    Lasani S. Wijetunge · 2009 · OpenGrey (Institut de l'Information Scientifique et Technique)
52. Original Article Seizure Susceptibility and Mortality in Mice that Over- Express Amyloid Precursor Protein
    Cara J. Westmark, Pamela R. Westmark, Ashley M. Beard · 2008
53. Investigação de elementos regulatórios do éxon 14 do gene Fmr1 e análise de expressão de suas isoformas
    Juliana da Cruz Corrêa · 2014 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
54. Behavioral and Immunological Phenotypes of Transgenic Mice Overexpressing Human Secreted Amyloid Precursor Protein Alpha: Implications for Autism
    Antoinette R. Bailey · 2012 · Digital Commons - University of South Florida (University of South Florida)
55. Original Article MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Aβ
    Cara J. Westmark, Pamela R. Westmark, James S. Malter · 2010
56. Identification of ADAM10 5`UTR binding proteins - The RNA-binding protein Unr is involved in ADAM10 mRNA stability
    Christian Haass · 2014
57. Novel regulation of neuronal genes implicated in Alzheimer disease by microRNA
    Justin M. Long · 2013 · IUScholarWorks (Indiana University)
58. Rôle de la protéine FMRP dans la formation et le dynamisme des granules à ARN
    Samia Mellaoui · 2012 · Corpus Université Laval (Université Laval)
59. Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
    Pedro Dionísio · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
60. The fragile X mental retardation protein in the regulation of neuronal mRNA translation and stability
    Silvia De Rubeis · 2010 · Cineca Institutional Research Information System (Tor Vergata University)
61. Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
    Faculdade De Farmácia · 2014
62. Clinicopathological Stratification of Idiopathic Autism and Autism with 15q11.2–q13 Duplications
    Jerzy Węgiel, N. Carolyn Schanen, Edwin H. Cook, William Ted Brown, Izabela Kuchna, Krzysztof Nowicki, Jarek Wegiel, Humi Imaki, Shuang Yong Ma, Eric London et al. · 2012 · Elsevier eBooks
63. FMRP and the Pathophysiology of Fragile X Syndrome
    Stephanie A. Barnes, Sophie R. Thomson, Peter C. Kind, Emily K. Osterweil · 2016 · Elsevier eBooks
64. Synthesis of a fluorinated 8-hydroxyquinoline derivative to explore the metal hypothesis of Alzheimer's disease
    Alina R. Kassenbrock · 2016
65. Drugs development and fragile X syndrome translational success story
    Dejan B. Budimirovic, Dragana D. Protic · 2016 · Medicinski podmladak
66. Cooperative Regulation of Translational Repression by FMRP and the miRNA Pathway
    Navneeta Kaul · 2018 · Digital Commons - DU (University of Denver)
67. Local translation of candidate mRNAs for Down's Syndrome
    Carina Teresa dos Santos Rodrigues · 2011 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
68. Signaling Mechanisms of Down Syndrome Cell Adhesion Molecule in Presynaptic Arbor Size Control.
    Gabriella R Sterne · 2016 · Deep Blue (University of Michigan)
69. On-tissue spatial proteomics integrating MALDI-MS imaging with shotgun proteomics reveals soy consumption-induced biomarkers in a fragile X syndrome mouse model
    Mengyao Ma, Qinying Yu, Daniel G. Delafield, Yusi Cui, Zihui Li, Wenxin Wu, Xudong Shi, Alejandra Gutierrez, Pamela R. Westmark, Meng Jiao Xu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
70. Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networks
    Niall Murphy · 2021 · OSF Preprints (OSF Preprints)
71. Humanização em terapia intensiva - Aspectos iniciais
    Firmino Haag Ferreira · 2021 · Editora Conhecimento Livre eBooks
72. Clustering and analysis of g quadruplex sequences.
    Aryan Neupane · 2023 · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
73. Application of Cadherin cRNA Probes in Brains of Alzheimer’s Disease Mouse Model
    Huiqin Zhou, S. J. Du, Fred Gendi, Hongyu Li, J. Fu, C. Chang · 2024 · Molecular Biology
74. SIEVEseq: One-stop differential expression, variability, and skewness analyses using RNA-Seq data
    Hongxiang Li, Tsung Fei Khang · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
75. A Valuable Target for Therapy: The Metalloproteinase ADAM10
    Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2025 · Current Protein and Peptide Science
76. Development of Therapeutic Agents Targeting Higher-order Structures of Nucleic Acids in Neurodegenerative Diseases
    Norifumi Shioda · 2025 · YAKUGAKU ZASSHI
77. FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway
    Shanshan Zhao, Xiangyu Jiang, Yiru Jiang, Jian Meng, Linkun Han, Jing Cao, Meng Tong Zhu, Yunqiang Zhou, Xian Zhang, Hong Luo et al. · 2025 · Neurobiology of Disease
78. Involvement of mGluR5/Homer crosstalk disruption in the pathophysiology of Fragile X Syndrome
    Elisabetta Aloisi · 2015 · theses.fr (ABES)
79. Rôle des protéines de liaison à l'ARN hnRNP H et hnRNP F dans les régulations traductionnelles dans les glioblastomes
    Morgane Le Bras · 2018 · theses.fr (ABES)
80. Deciphering the role of G-quadruplexes and their interacting proteins in malaria parasite Plasmodium falciparum
    Pratima Gurung · 2020
81. Pathophysiological consequences of a Fragile X missense mutation
    Marta Prieto Garcia · 2020 · theses.fr (ABES)
82. Rôle de la phosphodiestérase 2A dans la physiopathologie du syndrome de l’X fragile
    Sébastien Delhaye · 2021 · theses.fr (ABES)
83. SIEVEseq: unified differential expression, variability, and skewness analyses using RNA-Seq data
    Hongxiang Li, Tsung Fei Khang · 2026 · DNA Research
84. Therapeutic targeting of G protein-coupled receptors in central nervous system disorders: from novel mechanisms to precision pharmacology
    Chicheng Zhou, ChunTing Zhu, Xueying Wang, Yang Yang, Jinhuan Wei · 2026 · European Journal of Pharmacology
85. Genetic and pharmacological modulation of metabotropic glutamate receptors and cognition in animal models: A systematic review
    Sunjun Huh, Kohei Yamada, Saki Homma, Takahide Etani, Ryoma Kani, Tony Kaku, Keisuke Saito, Amaki Tsukazaki, Takanori Saka, Ayuka Takase et al. · 2026 · Research Square
86. Autism: epidemiology, genetics, molecular mechanisms, clinical features, diagnosis, and management
    Ruonan Fan, Yilin Wang, Tingting Miao · 2026 · Molecular Biomedicine
87. From developmental divergence to degenerative vulnerability: convergent molecular mechanisms linking autism spectrum disorder and Alzheimer’s disease
    Christian Griñán‐Ferré, Fahad Hussain, Aina Bellver‐Sanchís, N. Pérez-Salvador, Yeminia Valle, Daniel Ortuño‐Sahagún, Óscar Arias-Carrión · 2026 · Frontiers in Molecular Neuroscience
88. Inhibitory neurotransmission in the Fmr1 knockout mouse model of Fragile X Syndrome : region- and circuit-specific deficits
    Scott M. Paluszkiewicz · 2011 · DigitalGeorgetown (Georgetown University Library)
89. Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network
    D’Incal, Claudio, Broos, Jitse, Torfs, Thierry, Kooy, R. Frank, Vanden Berghe, Wim · 2022 · Cells